DE3784080T2 - Antivirales therapeutikum. - Google Patents

Antivirales therapeutikum.

Info

Publication number
DE3784080T2
DE3784080T2 DE8888901147T DE3784080T DE3784080T2 DE 3784080 T2 DE3784080 T2 DE 3784080T2 DE 8888901147 T DE8888901147 T DE 8888901147T DE 3784080 T DE3784080 T DE 3784080T DE 3784080 T2 DE3784080 T2 DE 3784080T2
Authority
DE
Germany
Prior art keywords
liposome
protein
antiviral therapeutic
envelope
engulf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888901147T
Other languages
English (en)
Other versions
DE3784080D1 (en
Inventor
Slobodan Tepic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AO FORSCHUNGSINST
Original Assignee
AO FORSCHUNGSINST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AO FORSCHUNGSINST filed Critical AO FORSCHUNGSINST
Application granted granted Critical
Publication of DE3784080D1 publication Critical patent/DE3784080D1/de
Publication of DE3784080T2 publication Critical patent/DE3784080T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888901147T 1987-12-19 1987-12-19 Antivirales therapeutikum. Expired - Fee Related DE3784080T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1987/000806 WO1989005633A1 (en) 1987-12-19 1987-12-19 Anti-viral therapeutic composition

Publications (2)

Publication Number Publication Date
DE3784080D1 DE3784080D1 (en) 1993-03-18
DE3784080T2 true DE3784080T2 (de) 1993-05-27

Family

ID=8165225

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888901147T Expired - Fee Related DE3784080T2 (de) 1987-12-19 1987-12-19 Antivirales therapeutikum.

Country Status (5)

Country Link
EP (1) EP0346343B1 (de)
JP (1) JPH02502633A (de)
AT (1) ATE85215T1 (de)
DE (1) DE3784080T2 (de)
WO (1) WO1989005633A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5026557A (en) * 1987-09-09 1991-06-25 The Liposome Company, Inc. Adjuvant composition
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
WO2014116723A1 (en) * 2013-01-22 2014-07-31 The Charles Stark Draper Laboratory, Inc. Multivalent liposome formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
DE2942780A1 (de) * 1979-10-23 1981-05-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Eukaryotische zellen, eukaryotische protoplasten und vielzellige eukaryotische lebende organismen mit einem gehalt an durch lipidvesikel eingebrachter dna, verfahren zu ihrer herstellung von gen-produkten, zur immunisierung und zur behebung genetisch bedingter defekte
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4652257A (en) * 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US4663161A (en) * 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
FR2592893A1 (fr) * 1986-01-15 1987-07-17 Pasteur Institut Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus.

Also Published As

Publication number Publication date
EP0346343A1 (de) 1989-12-20
JPH02502633A (ja) 1990-08-23
WO1989005633A1 (en) 1989-06-29
EP0346343B1 (de) 1993-02-03
ATE85215T1 (de) 1993-02-15
DE3784080D1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
AU3332089A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
IT1236688B (it) Procedimento e dispositivo per la creazione di una miscela combustibile-aria comburente da addurre a una combustione.
IT1224421B (it) Galattomannani modificati e realtivo procedimento di preparazione
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
ZA831854B (en) Small peptides with the specificity of foot and mouth disease viral antigens
KR870700638A (ko) 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도
TR22455A (tr) Siyano-3-fenoksi-4-florobenzil permetrat'in belirli gurup ciftlerinin hazirlanmasi icin usul
BR8703379A (pt) Disposicao combinada de controle de mao e pe
FR2462167B1 (fr) Interferon de fibroplastes humains sous la forme d'une proteine homogene et sa preparation
DE3784080T2 (de) Antivirales therapeutikum.
IT8619072A0 (it) Miglioramenti relativi a preparati virali di isolamento e al loro uso.
NO171242C (no) Fremgangsmaate for fremstilling av hudpleiepreparater med keratolytisk og antiinflammatorisk virkning
IT1214598B (it) Uso terapeutico della fosfocreatina.
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
DK141090A (da) Fremstilling af human prourokinase
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
Brattland et al. Shrinkage and flexural tests of two full-scale composite trusses
AU7008687A (en) Improvements in and relating to vaccines
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
SE8705060D0 (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
MX6262A (es) Procedimiento para la preparacion de una composicion sustancialmente estable y relativamente no higroscopica y composicion obtenida
RO91910A2 (ro) Preparat medicamentos trofic si energizant
AU7873587A (en) Assay to detect the presence of live hepatitis virus in vitro

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee